In today’s briefing:
- Ark Invest x Glassnode: The Decentralization Spectrum
- Asana’s Enterprise AI Push Gains Momentum As $100,000+ Customers Grow 16%!
- Electra Therapeutics (ETRA): Electra Looks to Keep Biotech IPO Momentum Charged
- US Wheat: September-2026
- Ondas Buyout Move: Inside The $205 Million Defense Expansion!
- Ambarella’s $8.5 Billion To $22.9 Billion TAM Expansion — Can It Convert?
- US Corn: September-2026
- The Venezuela Oil Deal: A Decade-Out Supply Story Dressed as a Headline
- UiPath’s Million-Dollar Customers Surge 21% As Enterprise Adoption Deepens!
- Zscaler’s $770 Million Z-Flex Surge — A New Growth Engine Takes Shape!
Ark Invest x Glassnode: The Decentralization Spectrum
- The Decentralization Spectrum: Design Tradeoffs In Digital Assets is a joint report by ARK Invest and Glassnode that maps Bitcoin, Ethereum, and Solana across four design features and six measurable dimensions of decentralization.
- Decentralization and centralization are architectures at two ends of digital asset network design.
- While “decentralized” and “centralized” networks seem to be binary alternatives, the reality is more nuanced. Blockchain design choices fall along a spectrum.
Asana’s Enterprise AI Push Gains Momentum As $100,000+ Customers Grow 16%!
- Asana, Inc. reported second-quarter fiscal 2027 revenue of $216.4 million, up 10% year-over-year and above the high end of guidance.
- Growth was led by core customers spending at least $5,000 annually, which increased 11%, and enterprise customers spending at least $100,000, which grew 16%.
- Dollar-based net retention improved to 97% overall and 98% across core and enterprise customers, supported by healthier seat expansion and multiproduct adoption including AI.
Electra Therapeutics (ETRA): Electra Looks to Keep Biotech IPO Momentum Charged
- Electra is developing precision immunotherapies designed to selectively eliminate disease-driving immune cells while preserving normal immune function.
- Ipsoprubart has generated encouraging early data in malignancy-associated HLH, including 100% overall survival and overall response in 12 frontline patients.
- Sector momentum and current demand are constructive, with all four August biotech IPOs trading above issue prices and Electra’s book reportedly oversubscribed.
US Wheat: September-2026
- Sentiment: Cautious Bearish, conditional on Black Sea export disruption easing
- Chicago SRW wheat futures (ZW) December 2026 closed at $7.4125 per bushel on 10 September.
- The rally primarily reflects the Russia-Ukraine conflict disrupting Black Sea exports.
Ondas Buyout Move: Inside The $205 Million Defense Expansion!
- Ondas has taken another major step in expanding its autonomous defense platform through the acquisition of Israel-based GATE Technologies and affiliated Bron Technologies for $205 million.
- The transaction comes as Ondas aggressively scales its exposure to Precision Strike, Counter-UAS, persistent intelligence, and autonomous defense systems under its broader One Ondas strategy.
- GATE manufactures Electronic Safe & Arm Devices, or ESADs, and advanced electronic fuzing systems used in UAVs, loitering munitions, missiles, and rockets, while Bron adds manufacturing capacity in Poland and access to European defense customers.
Ambarella’s $8.5 Billion To $22.9 Billion TAM Expansion — Can It Convert?
- Ambarella, Inc. reported its financial results for the second quarter of fiscal year 2027 with revenue reaching $108.1 million, slightly above the midpoint of its guidance and representing increases of 7.7% sequentially and 13.2% year-over-year.
- The company’s performance was driven by record edge AI revenue and growth in both its Internet of Things (IoT) and automotive markets, particularly from commercial vehicle applications.
- Automotive revenue slightly outpaced IoT growth, and non-GAAP earnings per share stood at $0.18.
US Corn: September-2026
- Sentiment: Cautious Bearish, on a record managed-money long meeting a report that missed on the bearish side, with no flat-price information advantage in a settled crop.
- Treefera’s crop size agrees with the government’s, so the national number holds no edge.
- What is left to trade is which states grew the corn, and who is holding the position. Both sit outside the balance sheet the market is still trading.
The Venezuela Oil Deal: A Decade-Out Supply Story Dressed as a Headline
- Washington is betting on Venezuelan oil: NABEP gives the U.S. unprecedented influence over future production, including equity, governance rights and priority access to output.
- The supply impact is distant: NABEP’s current production is far below its target, while infrastructure, capital and field development could push meaningful new volumes into the 2030s.
- Hormuz remains a different story: Venezuelan production cannot offset today’s disruption risk, leaving the current geopolitical premium largely intact despite the long-term supply option.
UiPath’s Million-Dollar Customers Surge 21% As Enterprise Adoption Deepens!
- UiPath Incorporated reported its second quarter fiscal 2027 results with a 12% year-over-year increase in annual recurring revenue (ARR) reaching $1.938 billion and 13% revenue growth to $410 million.
- Normalizing for foreign exchange (FX) impacts, revenue growth was approximately 16%.
- The company continued its trend of GAAP profitability for the fourth consecutive quarter, with GAAP operating income improving to $32 million from a prior year operating loss, and achieved a non-GAAP operating margin of 22%, up over 400 basis points year-over-year, driven by operational efficiencies and disciplined execution.
Zscaler’s $770 Million Z-Flex Surge — A New Growth Engine Takes Shape!
- Zscaler, Inc. reported its fourth quarter and full fiscal year 2026 results highlighting continued robust growth and strategic positioning for the expanding cybersecurity market, particularly around AI security.
- The company achieved 25% year-over-year growth in annual recurring revenue (ARR), reaching $3.8 billion, driven by broad-based demand across multiple geographies and customer segments.
- Net new ARR grew 24% year-over-year, accelerating to 17% excluding the contribution from its recent acquisition of Red Canary.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars
